Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cashflow Statement

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹1,465 Cr₹1,063 Cr₹1,133 Cr₹1,055 Cr₹1,619 Cr
Adjustment ₹277 Cr₹212 Cr₹224 Cr₹38 Cr₹-28 Cr
Changes In working Capital ₹-254 Cr₹-6.06 Cr₹-53 Cr₹-418 Cr₹-393 Cr
Cash Flow after changes in Working Capital ₹1,487 Cr₹1,269 Cr₹1,303 Cr₹675 Cr₹1,197 Cr
Cash Flow from Operating Activities ₹1,031 Cr₹915 Cr₹997 Cr₹364 Cr₹791 Cr
Cash Flow from Investing Activities ₹138 Cr₹1,705 Cr₹-1,757 Cr₹1,208 Cr₹-1,003 Cr
Cash Flow from Financing Activities ₹-417 Cr₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr
Net Cash Inflow / Outflow ₹752 Cr₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr
Opening Cash & Cash Equivalents ₹2,556 Cr₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹51 Cr₹13 Cr₹7.72 Cr₹3.00 Cr₹3.31 Cr
Closing Cash & Cash Equivalent ₹3,359 Cr₹2,556 Cr₹357 Cr₹1,909 Cr₹319 Cr

Compare Cashflow Statement of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,618.3 Cr -7.2% -3.1% 48.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-7.2%

-3.1%

48.9%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses